LBA69 Prostate cancer efficacy results from a randomised phase III evaluation of transdermal oestradiol (tE2) versus luteinising hormone releasing hormone agonists (LHRHa) for androgen suppression in non-metastatic (M0) prostate cancer.
Saved in:
| Title: | LBA69 Prostate cancer efficacy results from a randomised phase III evaluation of transdermal oestradiol (tE2) versus luteinising hormone releasing hormone agonists (LHRHa) for androgen suppression in non-metastatic (M0) prostate cancer. |
|---|---|
| Authors: | Langley, R.E.1 (AUTHOR), Nankivell, M.1 (AUTHOR), Gilbert, D.1 (AUTHOR), Bourmpaki, E.1 (AUTHOR), Mangar, S.2 (AUTHOR), Rush, H.L.1 (AUTHOR), Rosen, S.D.3 (AUTHOR), Alhasso, A.4 (AUTHOR), Kockelbergh, R.5 (AUTHOR), Marshall, J.1 (AUTHOR), Griffiths, A.1 (AUTHOR), Chan, K.H.Y.1 (AUTHOR), Mohamed, W.M.6 (AUTHOR), Dallas, N.L.7 (AUTHOR), Brown, S.J.8 (AUTHOR), Clarke, N.9 (AUTHOR), James, N.D.10 (AUTHOR), Parmar, M.K.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1258-S1258. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179693641 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: LBA69 Prostate cancer efficacy results from a randomised phase III evaluation of transdermal oestradiol (tE2) versus luteinising hormone releasing hormone agonists (LHRHa) for androgen suppression in non-metastatic (M0) prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Langley%2C+R%2EE%2E%22">Langley, R.E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nankivell%2C+M%2E%22">Nankivell, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gilbert%2C+D%2E%22">Gilbert, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bourmpaki%2C+E%2E%22">Bourmpaki, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mangar%2C+S%2E%22">Mangar, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rush%2C+H%2EL%2E%22">Rush, H.L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rosen%2C+S%2ED%2E%22">Rosen, S.D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alhasso%2C+A%2E%22">Alhasso, A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kockelbergh%2C+R%2E%22">Kockelbergh, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marshall%2C+J%2E%22">Marshall, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Griffiths%2C+A%2E%22">Griffiths, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chan%2C+K%2EH%2EY%2E%22">Chan, K.H.Y.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mohamed%2C+W%2EM%2E%22">Mohamed, W.M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dallas%2C+N%2EL%2E%22">Dallas, N.L.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brown%2C+S%2EJ%2E%22">Brown, S.J.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Clarke%2C+N%2E%22">Clarke, N.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22James%2C+N%2ED%2E%22">James, N.D.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parmar%2C+M%2EK%2E%22">Parmar, M.K.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS1258-S1258. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179693641 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.2312 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1258 Titles: – TitleFull: LBA69 Prostate cancer efficacy results from a randomised phase III evaluation of transdermal oestradiol (tE2) versus luteinising hormone releasing hormone agonists (LHRHa) for androgen suppression in non-metastatic (M0) prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Langley, R.E. – PersonEntity: Name: NameFull: Nankivell, M. – PersonEntity: Name: NameFull: Gilbert, D. – PersonEntity: Name: NameFull: Bourmpaki, E. – PersonEntity: Name: NameFull: Mangar, S. – PersonEntity: Name: NameFull: Rush, H.L. – PersonEntity: Name: NameFull: Rosen, S.D. – PersonEntity: Name: NameFull: Alhasso, A. – PersonEntity: Name: NameFull: Kockelbergh, R. – PersonEntity: Name: NameFull: Marshall, J. – PersonEntity: Name: NameFull: Griffiths, A. – PersonEntity: Name: NameFull: Chan, K.H.Y. – PersonEntity: Name: NameFull: Mohamed, W.M. – PersonEntity: Name: NameFull: Dallas, N.L. – PersonEntity: Name: NameFull: Brown, S.J. – PersonEntity: Name: NameFull: Clarke, N. – PersonEntity: Name: NameFull: James, N.D. – PersonEntity: Name: NameFull: Parmar, M.K. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
